02239nam 2200565 450 991078759190332120230803030543.01-78084-207-4(CKB)2670000000391289(EBL)1179630(OCoLC)851970658(SSID)ssj0001526192(PQKBManifestationID)11834621(PQKBTitleCode)TC0001526192(PQKBWorkID)11505974(PQKB)10487917(MiAaPQ)EBC1179630(Au-PeEL)EBL1179630(EXLCZ)99267000000039128920220517d2013 uy 0engur|n|---|||||txtccrCancer cachexia /editors Josep M. Argilés, Silvia Busquets1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (77 p.)Description based upon print version of record.1-78084-209-0 Title page; Copyright page; Contents; Foreword. Cancer cachexia; 1. Prevalence and clinical features of cancer cachexia; 2. Pathogenesis of cancer cachexia; 3. Current medications for cancer cachexia; 4. Latest developments in cachexia drug discovery: clinical trials; 5. Comorbidities and prognosis; IndexCancer cachexia is a multiorganic syndrome associated with neoplastic syndromes, characterized by a marked weight loss, anorexia, asthenia and anemia. This expertly authored book provides a comprehensive review of the mechanisms, mediators and treatment of cancer cachexia. The book represents a comprehensive expert review and summary of the current status of cancer cachexia and its therapy.CancerNutritional aspectsCachexiaCachexiaTreatmentCancerNutritional aspects.Cachexia.CachexiaTreatment.616.9940654Argilés Josep M.Busquets SilviaMiAaPQMiAaPQMiAaPQBOOK9910787591903321Cancer cachexia3730095UNINA